NewcelX Ltd.
NCEL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001783036
No open-market purchases or sales by NewcelX Ltd. insiders were filed in the last 90 days; 4 institutions reported holding it in 13F filings for Q2 2026, worth $42.6K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by NewcelX Ltd. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for NewcelX Ltd., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Revel Michel | CSO and Director | 957,530 | Apr 29, 2026 | 1 |
| Samuel Olivier | Director | 81,818 | Apr 29, 2026 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 29, 2026 (view filing) | Apr 27 | 2 days | Samuel OlivierDirector | PPurchaseCommon Shares, par value CHF 0.05 per share | +81.8K | $2.75 | +$225.0K | New position81.8K after | |
| Apr 29, 2026 (view filing) | Apr 27 | 2 days | Samuel OlivierDirector | PPurchaseCommon Shares, par value CHF 0.05 per share | +114.5K | – | – | –114.5K after | Derivative |
| Apr 29, 2026 (view filing) | Apr 27 | 2 days | Revel MichelCSO and Director | PPurchaseCommon Shares, par value CHF 0.05 per share | +54.5K | $2.75 | +$150.0K | +6.0%957.5K after | |
| Apr 29, 2026 (view filing) | Apr 27 | 2 days | Revel MichelCSO and Director | PPurchaseCommon Shares, par value CHF 0.05 per share | +76.4K | – | – | –76.4K after | Derivative |